Genome Structure Analysis Reagents
Early Cancer Detection
DevelopmentActive
Key Facts
About Avidin
Avidin is a diversified biotech firm with a dual focus on therapeutic discovery and molecular diagnostics. Its most advanced program is Q134R, a clinical candidate for Alzheimer's disease developed in partnership with Aperus Pharma. The company also maintains active research in oncology and inflammation, and provides preclinical services and diagnostic products, supported by international scientific and industrial collaborations.
View full company profileTherapeutic Areas
Other Early Cancer Detection Drugs
| Drug | Company | Phase |
|---|---|---|
| QSOX1-L Based Cancer Test | Axim Biotech | Prototype |
| Pearsanta | Aditx Therapeutics | Platform / Asset |